Phase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma

GSE22968

Homo sapiens

27 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the setting of isolated limb infusion

PubMed ID

21343562

Publication Title

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.

Total Samples

Submitter’s Institution

Duke University Medical Center

Authors

Beasley GM, Riboh JC, Augustine CK, Zager JS, Hochwald SN, Grobmyer SR, Peterson B, Royal R, Ross MI, Tyler DS

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-22968

No rows found